Effect of Real-time Continuous Glucose Monitoring on Glucose Control and Outcomes of Critically Ill Patients
研究概览
详细说明
研究类型
注册 (预期的)
阶段
- 不适用
联系人和位置
学习地点
-
-
Sichuan
-
Chengdu、Sichuan、中国、610000
- 招聘中
- Intensive care unit of West China Hospital
-
接触：
- Yan Kang, MD
- 电话号码：028-85422508
- 邮箱：kang_yan_123@163.com
-
首席研究员：
- Yan Kang, MD
-
副研究员：
- Yan-yan Zuo, MD
-
副研究员：
- Mei-zhu Lu, MD
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
More than 18 years old male or female;
Expected ICU stays longer than 72 hours;
Glucose level more than 8 mmol/L when enrolls in the ICU;
- Patients or their legal surrogates have signed the informed consent.
Exclusion Criteria:
Pregnant or lactating women;
ICU stays less than 72 hours;
- Usage of real-time continuous glucose monitoring system is considered as a contraindication.
学习计划
研究是如何设计的？
设计细节
- 主要用途：治疗
- 分配：随机化
- 介入模型：并行分配
- 屏蔽：双倍的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的：Continuous Glucose Monitoring Group
Continuous Glucose Monitoring Group: Different methods of blood glucose monitoring between groups, and this group will use real-time continuous glucose monitoring system with alarm limits（high and low limit is 10 mmol/L and 8 mmil/L , respectively ) up to five days for glucose control, the target mean glucose level is between 8 and 10 mmol/L. |
Finger prick blood glucose in conventional group versus real-time continuous glucose monitoring system of continuous glucose monitoring group
|
|
有源比较器：Conventional Group
Conventional Group： Different methods of blood glucose monitoring between groups, and this group will use finger prick blood glucose measurements for glucose control with the same target mean glucose level of 8 -10 mmol/L. Patients also wear real-time continuous glucose monitoring system to collect glucose measurements. The values of real-time continuous glucose monitoring system are blinded to investigator and patients. |
Finger prick blood glucose in conventional group versus real-time continuous glucose monitoring system of continuous glucose monitoring group
|
研究衡量的是什么？
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
Glycemic Control Measures including: Percentage of target blood glucose levels (defined as between 8mmol/L and 10mmol/L); Time of hyperglycemia (defined as >10mmol/L); Hypoglycemia rate (defined as < 2.2mmol/L); Glucose lability index
大体时间：Glycemic control measures will be assessed up to five days.
|
Glycemic control measures will be assessed up to five days.
|
次要结果测量
结果测量 |
大体时间 |
|---|---|
|
Prognosis Measures including: Duration of mechanical ventilation；Time of ICU stay; Time of hospital stay; 28 days - mortality rate
大体时间：All the participants will be followed for the duration of hospital stay or 28 days.
|
All the participants will be followed for the duration of hospital stay or 28 days.
|
|
Cost
大体时间：Cost associated with glucose monitoring
|
Cost associated with glucose monitoring
|
合作者和调查者
赞助
调查人员
- 研究主任：Yan Kang, MD、West China Hospital
研究记录日期
研究主要日期
学习开始
初级完成 (预期的)
研究完成 (预期的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (估计)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他研究编号
- CGM-ky0521
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.